• Je něco špatně v tomto záznamu ?

Regulatory T cells suppress the formation of potent KLRK1 and IL-7R expressing effector CD8 T cells by limiting IL-2

O. Tsyklauri, T. Chadimova, V. Niederlova, J. Kovarova, J. Michalik, I. Malatova, S. Janusova, O. Ivashchenko, H. Rossez, A. Drobek, H. Vecerova, V. Galati, M. Kovar, O. Stepanek

. 2023 ; 12 (-) : . [pub] 20230127

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc23004503

Grantová podpora
FunDiT European Research Council - International

Regulatory T cells (Tregs) are indispensable for maintaining self-tolerance by suppressing conventional T cells. On the other hand, Tregs promote tumor growth by inhibiting anticancer immunity. In this study, we identified that Tregs increase the quorum of self-reactive CD8+ T cells required for the induction of experimental autoimmune diabetes in mice. Their major suppression mechanism is limiting available IL-2, an essential T-cell cytokine. Specifically, Tregs inhibit the formation of a previously uncharacterized subset of antigen-stimulated KLRK1+ IL-7R+ (KILR) CD8+ effector T cells, which are distinct from conventional effector CD8+ T cells. KILR CD8+ T cells show superior cell-killing abilities in vivo. The administration of agonistic IL-2 immunocomplexes phenocopies the absence of Tregs, i.e., it induces KILR CD8+ T cells, promotes autoimmunity, and enhances antitumor responses in mice. Counterparts of KILR CD8+ T cells were found in the human blood, revealing them as a potential target for immunotherapy.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23004503
003      
CZ-PrNML
005      
20230425141443.0
007      
ta
008      
230418s2023 enk f 000 0|eng||
009      
AR
024    7_
$a 10.7554/eLife.79342 $2 doi
035    __
$a (PubMed)36705564
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Tsyklauri, Oksana $u Laboratory of Adaptive Immunity, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic $u Faculty of Science, Charles University, Prague, Czech Republic $1 https://orcid.org/0000000199975913
245    10
$a Regulatory T cells suppress the formation of potent KLRK1 and IL-7R expressing effector CD8 T cells by limiting IL-2 / $c O. Tsyklauri, T. Chadimova, V. Niederlova, J. Kovarova, J. Michalik, I. Malatova, S. Janusova, O. Ivashchenko, H. Rossez, A. Drobek, H. Vecerova, V. Galati, M. Kovar, O. Stepanek
520    9_
$a Regulatory T cells (Tregs) are indispensable for maintaining self-tolerance by suppressing conventional T cells. On the other hand, Tregs promote tumor growth by inhibiting anticancer immunity. In this study, we identified that Tregs increase the quorum of self-reactive CD8+ T cells required for the induction of experimental autoimmune diabetes in mice. Their major suppression mechanism is limiting available IL-2, an essential T-cell cytokine. Specifically, Tregs inhibit the formation of a previously uncharacterized subset of antigen-stimulated KLRK1+ IL-7R+ (KILR) CD8+ effector T cells, which are distinct from conventional effector CD8+ T cells. KILR CD8+ T cells show superior cell-killing abilities in vivo. The administration of agonistic IL-2 immunocomplexes phenocopies the absence of Tregs, i.e., it induces KILR CD8+ T cells, promotes autoimmunity, and enhances antitumor responses in mice. Counterparts of KILR CD8+ T cells were found in the human blood, revealing them as a potential target for immunotherapy.
650    _2
$a zvířata $7 D000818
650    _2
$a lidé $7 D006801
650    _2
$a myši $7 D051379
650    _2
$a CD8-pozitivní T-lymfocyty $7 D018414
650    12
$a diabetes mellitus 1. typu $x patologie $7 D003922
650    _2
$a imunologická tolerance $7 D007108
650    _2
$a interleukin-2 $7 D007376
650    _2
$a lektinové receptory NK-buněk - podrodina K $7 D055655
650    12
$a regulační T-lymfocyty $7 D050378
650    _2
$a receptory interleukinu-7 $7 D020395
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Chadimova, Tereza $u Laboratory of Adaptive Immunity, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic $u Faculty of Science, Charles University, Prague, Czech Republic
700    1_
$a Niederlova, Veronika $u Laboratory of Adaptive Immunity, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic $u Faculty of Science, Charles University, Prague, Czech Republic $1 https://orcid.org/0000000187689039
700    1_
$a Kovarova, Jirina $u Institute of Microbiology of the Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Michalik, Juraj $u Laboratory of Adaptive Immunity, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic $1 https://orcid.org/0000000184790991
700    1_
$a Malatova, Iva $u Institute of Microbiology of the Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Janusova, Sarka $u Laboratory of Adaptive Immunity, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic $1 https://orcid.org/000000020111497X
700    1_
$a Ivashchenko, Olha $u Laboratory of Adaptive Immunity, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic $1 https://orcid.org/0000000256110933
700    1_
$a Rossez, Helene $u Department of Biomedicine, University Hospital of Basel, Basel, Switzerland
700    1_
$a Drobek, Ales $u Laboratory of Adaptive Immunity, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Vecerova, Hana $u Laboratory of Adaptive Immunity, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Galati, Virginie $u Department of Biomedicine, University Hospital of Basel, Basel, Switzerland
700    1_
$a Kovar, Marek $u Institute of Microbiology of the Czech Academy of Sciences, Prague, Czech Republic $1 https://orcid.org/0000000266021678
700    1_
$a Stepanek, Ondrej $u Laboratory of Adaptive Immunity, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic $u Department of Biomedicine, University Hospital of Basel, Basel, Switzerland $1 https://orcid.org/0000000227353311
773    0_
$w MED00188753 $t eLife $x 2050-084X $g Roč. 12, č. - (2023)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36705564 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230418 $b ABA008
991    __
$a 20230425141439 $b ABA008
999    __
$a ok $b bmc $g 1924919 $s 1190712
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 12 $c - $e 20230127 $i 2050-084X $m eLife $n eLife $x MED00188753
GRA    __
$a FunDiT $p European Research Council $2 International
LZP    __
$a Pubmed-20230418

Najít záznam

Citační ukazatele

Možnosti archivace